NYSE American - Delayed Quote USD

IGC Pharma, Inc. (IGC)

0.4390 -0.0176 (-3.85%)
At close: 4:00 PM EDT
0.4180 -0.02 (-4.78%)
After hours: 5:01 PM EDT

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 1111
Avg. Estimate -0.04-0.04-0.22-0.16
Low Estimate -0.04-0.04-0.22-0.16
High Estimate -0.04-0.04-0.22-0.16
Year Ago EPS -------0.22

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 1111
Avg. Estimate 190k620k1.24M1.4M
Low Estimate 190k620k1.24M1.4M
High Estimate 190k620k1.24M1.4M
Year Ago Sales ------1.24M
Sales Growth (year/est) ------12.90%

Earnings History

CURRENCY IN USD
EPS Est. --------
EPS Actual --------
Difference --------
Surprise % --------

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate -0.04-0.04-0.22-0.16
7 Days Ago -0.04-0.04-0.22-0.16
30 Days Ago -0.04-0.04-0.22-0.16
60 Days Ago -0.04-0.04-0.22-0.16
90 Days Ago 0000

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD IGCIndustrySectorS&P 500
Current Qtr. ------1.50%
Next Qtr. ------11.40%
Current Year ------5.20%
Next Year 27.30%----13.40%
Next 5 Years (per annum) ------11.09%
Past 5 Years (per annum) --------

Research Analysis

Analyst Price Targets

3.25
3.25 Average
0.4390 Current
3.25 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Related Tickers